Chronic Inhibition of Nitric Oxide Ameliorates Splanchnic Hyposensitivity to Glypressin in a Hemorrhage-transfused Rat Model of Portal Hypertension

References

• D’Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995;22:332–54.
   Google Scholar
• Valla D, Geoffroy P, Girod C, Lebrec D. Circulatory actions of vasopressin in anaesthetized rats with portal hypertension subjected to haemorrhage. J Hepatol 1986;2:328–39.
   PubMed Web of Science ®Google Scholar
• Kravetz D, Cummings SA, Groszmann RJ. Hyposensitivity to vasopressin in a hemorrhage-transfused rat model of portal hypertension. Gastroenterology 1987;93:170–5.
   Google Scholar
• Valla D, Girod C, Lee SS, Braillon A, Lebrec D. Lack of vasopressin action on splanchnic hemodynamics during bleeding: a study in conscious, portal hypertensive rats. Hepatology 1988;8:10–5.
   Google Scholar
• Tsai YT, Lee FY, Lin HC, Lee SD, Hsia HC, Lin WJ, et al. Hyposensitivity to vasopressin in patients with hepatitis B-related cirrhosis during acute variceal bleeding. Hepatology 1990;13:407–12.
   Google Scholar
• Chu CJ, Lee FY, Wang SS, Chang FY, Lin HC, Hou MC, et al. Aminoguanidine ameliorates splanchnic hyposensitivity to glypressin in a haemorrhage-transfused rat model of portal hypertension. Clin Sci 1998;95:629–36.
   Web of Science ®Google Scholar
• Paller MS, Linas SL. Role of angiotensin II, alpha-adrenergic system and arginine vasopressin on arterial pressure in the rat. Am J Physiol 1984;246:H25–30.
   PubMed Web of Science ®Google Scholar
• Haddy FT, Scott JB, Molnar JI. Mechanism of volume replacement and vascular constriction following haemorrhage. Am J Physiol 1965;208:169–81.
   Google Scholar
• Vorobioff J, Bredfeldt JE, Groszmann RJ. Hyperdynamic circulation in portal hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol 1983;244:G52–7.
   Google Scholar
• Schrier RW, Caramelo C. Haemodynamic and hormonal alternations in hepatic cirrhosis. In: Epstein M, editor. The kidney in liver disease. Baltimore (MD): Williams & Wilkins; 1988. p. 265–85.
   Google Scholar
• Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991;337:776–8.
   PubMed Web of Science ®Google Scholar
• Bomzon A, Blendis LM. The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis. Hepatology 1994;20: 1343–50.
   PubMed Web of Science ®Google Scholar
• Lee FY, Albillos A, Colombato LA, Groszmann RJ. The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats. Hepatology 1992;16:1043–8.
   PubMed Web of Science ®Google Scholar
• Sieber CC, Groszmann RJ. In vitro hyporeactivity to methox-amine in portal hypertensive rats: reversal by nitric oxide inhibition. Am J Physiol 1992;262:G996–1001.
   PubMed Web of Science ®Google Scholar
• Pizcueta P, Piqué JM, Fernandéz M, Bosch J, Rodes J, Whittle BJ, et al. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 1992;103:1909–15.
   PubMed Web of Science ®Google Scholar
• Lee FY, Colombato LA, Albillos A, Groszmann RJ. Administration of Nω-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats. Gastroenterology 1993;105: 1464–70.
   PubMed Web of Science ®Google Scholar
• Thiemermann C, Szabó C, Mitchell JA, Vane JR. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci USA 1993;90:267–71.
   PubMed Web of Science ®Google Scholar
• Pilette C, Moreau R, Sogni P, Kirstetter P, Cailmail S, Pussard E, et al. Haemodynamic and hormonal responses to long-term inhibition of nitric oxide synthesis in rats with portal hypertension. Eur J Pharmacol 1996;312:63–8.
   PubMedGoogle Scholar
• Chojkier M, Groszmann RJ. Measurement of the portal-systemic shunting in the rat by using γ-labeled microspheres. Am J Physiol 1981;240:G371–5.
   PubMed Web of Science ®Google Scholar
• Lee FY, Wang SS, Tsai YT, Lin HJ, Chu CJ, et al. Amino-guanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats. J Hepatol 1997;26: 687–93.
   PubMed Web of Science ®Google Scholar
• Miller VM, Vanhoutte P. Endothelium-dependent responses and their potential relevance to the distribution of blood flow during haemorrhagic shock. Resuscitation 1989;18:165–71.
   PubMedGoogle Scholar
• Ayala A, Perrin MM, Meldrum DR, Ertel W, Chaudry IH. Differential effects of hemorrhage on Kupffer cells: decreased antigen presentation despite increased inflammatory cytokine (IL-1, IL-6 and TNF) release. Cytokine 1990;2: 170–4.
   Google Scholar
• Ayala A, Wang P, Ba ZF, Perrin MM, Ertel W, Chaudry IH. Differential alterations in plasma IL-6 and TNF levels after trauma and hemorrhage. Am J Physiol 1991;260:R167–71.
   PubMed Web of Science ®Google Scholar
• Gräfe M, Bossaller C, Graf K, Auch-Schwelk W, Baumgarten CR, Hildebrandt A, et al. Effects of angiotensin-convertingenzyme inhibition on bradykinin metabolism by vascular endothelial cells. Am J Physiol 1993;264:H1493–7.
   Google Scholar
• Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43: 109–42.
   Google Scholar
• Haddy FT, Scott JB, Molnar JI. Mechanism of volume replacement and vascular constriction following hemorrhage. Am J Physiol 1965;208:169–81.
   Google Scholar
• Zebre RL, Bayorth MA, Feuerstein G. Vasopressin: an essential pressor factor for blood pressure recovery following hemorrhage. Peptides 1982;3:509–14.
   Google Scholar
• Chien S. Role of sympathetic nerves system in hemorrhage. Physiol Rev 1967;47:214–88.
   PubMed Web of Science ®Google Scholar
• Niederberger M, Gines P, Martin PY, Tsai P, Morris K, Mcmurtry I, et al. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus pre-hepatic portal hypertension in rats. Hepatology 1996;24:947–51.
   PubMedGoogle Scholar